Insider10% Owner
Novo Holdings A/S Insider Trading Activity
Every SEC Form 4 transaction reported by Novo Holdings A/S, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Novo Holdings A/S buying or selling?
Novo Holdings A/S reported 28 open-market buys ($217.0M) and 27 sells ($189.5M) across 55 Form 4 filings at 27 companies — a net buying position of $27.5M.
Source: SEC EDGAR Form 4
What stands out
- Novo Holdings A/S has reported Form 4 transactions at 27 companies; the most active, Cyteir Therapeutics, Inc. (CYT), accounts for 9 of 55 filings (16%).
- The most recent Form 4 was accepted on May 5, 2026 (5 months ago).
- In the last 12 months: 2 open-market purchases ($26.2M) and no sales.
- The largest open-market purchase in the last 12 months was $16.2M of MapLight Therapeutics, Inc. (MPLT) on Oct 30, 2025. SEC ↗
Key Statistics (as of May 5, 2026)
Total Form 4 filings
55
SEC EDGAR
Companies
27
Buys (28)
$217.0M
Sells (27)
$189.5M
Insider sentiment
Net buyingNet insider flow of $27.5M in net buying, filed between Mar 13, 2018 – May 5, 2026.
Companies Novo Holdings A/S files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | CYTCyteir Therapeutics, Inc. | 9 |
| 2 | SPRBSPRUCE BIOSCIENCES, INC. | 6 |
| 3 | IOBTQIO Biotech, Inc. | 5 |
| 4 | CRVSCorvus Pharmaceuticals, Inc. | 3 |
| 5 | GRTXGalera Therapeutics, Inc. | 3 |
| 6 | BOLTBolt Biotherapeutics, Inc. | 2 |
| 7 | CMPICheckmate Pharmaceuticals, Inc. | 2 |
| 8 | EWTXEdgewise Therapeutics, Inc. | 2 |
| 9 | INGNInogen Inc | 2 |
| 10 | INZYInozyme Pharma, Inc. | 2 |
Recent Novo Holdings A/S transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| May 5, 2026 | AVLN | 10% Owner | Purchase | 555.6K | $10.0M | SEC ↗ |
| Oct 30, 2025 | MPLT | 10% Owner | Purchase | 952.9K | $16.2M | SEC ↗ |
| Jul 27, 2024 | IOBTQ | 10% Owner | Sale | 75.0K | $99.1K | SEC ↗ |
| May 15, 2024 | IOBTQ | 10% Owner | Sale | 658.8K | $802.5K | SEC ↗ |
| Mar 26, 2024 | SPRB | 10% Owner | Sale | 465.0K | $351.0K | SEC ↗ |
| Mar 21, 2024 | SPRB | 10% Owner | Sale | 1.8M | $1.4M | SEC ↗ |
| Mar 19, 2024 | SPRB | 10% Owner | Sale | 1.9M | $1.7M | SEC ↗ |
| Feb 16, 2024 | MGX | 10% Owner | Purchase | 900.0K | $13.0M | SEC ↗ |
| Feb 14, 2024 | IOBTQ | 10% Owner | Sale | 658.8K | $988.4K | SEC ↗ |
| Aug 11, 2023 | IOBTQ | 10% Owner | Purchase | 2.5M | $5.0M | SEC ↗ |
| Jul 21, 2023 | CYT | 10% Owner | Sale | 101.9K | $280.4K | SEC ↗ |
| Jul 19, 2023 | CYT | 10% Owner | Sale | 38.6K | $106.0K | SEC ↗ |
| Jul 3, 2023 | CYT | 10% Owner | Sale | 200.9K | $529.3K | SEC ↗ |
| Jun 29, 2023 | CYT | 10% Owner | Sale | 40.4K | $71.8K | SEC ↗ |
| Jun 28, 2023 | IRON | 10% Owner | Sale | 1.3M | $57.6M | SEC ↗ |
| Jun 23, 2023 | CYT | 10% Owner | Sale | 13.3K | $25.9K | SEC ↗ |
| Jun 23, 2023 | OKUR | 10% Owner | Sale | 100.0K | $709.7K | SEC ↗ |
| Jun 20, 2023 | CYT | 10% Owner | Sale | 16.7K | $34.0K | SEC ↗ |
| Jun 15, 2023 | CYT | 10% Owner | Sale | 6.4K | $13.4K | SEC ↗ |
| Feb 21, 2023 | SPRB | 10% Owner | Purchase | 2.2M | $7.0M | SEC ↗ |
| Sep 16, 2022 | EWTX | 10% Owner | Purchase | 484.5K | $5.0M | SEC ↗ |
| Jul 22, 2022 | CYT | 10% Owner | Sale | 900.0K | $2.7M | SEC ↗ |
| Jul 15, 2022 | BOLT | 10% Owner | Sale | 800.0K | $1.6M | SEC ↗ |
| Feb 25, 2022 | CMPI | 10% Owner | Sale | 8.1K | $23.1K | SEC ↗ |
| Feb 9, 2022 | ACLX | 10% Owner | Purchase | 833.3K | $12.5M | SEC ↗ |
Showing the 25 most recent filings of 55. Screen every filing.
Novo Holdings A/S insider trading FAQ
Is Novo Holdings A/S buying or selling?
Across 55 SEC Form 4 filings, Novo Holdings A/S reported 28 open-market purchases totaling $217.0M and 27 sales totaling $189.5M — a net buying position of $27.5M.
Which companies does Novo Holdings A/S file Form 4s for?
Novo Holdings A/S has reported insider transactions at 27 companies, most often Cyteir Therapeutics, Inc. (CYT), SPRUCE BIOSCIENCES, INC. (SPRB), IO Biotech, Inc. (IOBTQ), Corvus Pharmaceuticals, Inc. (CRVS), Galera Therapeutics, Inc. (GRTX).
How far back does Novo Holdings A/S's filing history go?
Trabud holds Novo Holdings A/S's SEC Form 4 filings from Mar 13, 2018 – May 5, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Novo Holdings A/S's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Novo Holdings A/S and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener